Rossari Biotech (BOM:543213) Total Equity: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543213 Rossari Biotech Ltd BOM:543213
84 GF Score
Price ₹489.30
GF Value ₹967.22
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Rossari Biotech Total Equity?

Rossari Biotech BOM:543213 -0.37% 84 Total Equity is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:543213 with a GF Score™ of 84/100 and a GF Value™ of ₹967.22 (Possible Value Trap). The stock has 4 warning signs investors should review.

Rossari Biotech's total equity for the quarter that ended in Jun. 2026 was ₹0 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Rossari Biotech Total Equity Historical Data

* Premium members only.

The historical data trend for Rossari Biotech's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rossari Biotech Total Equity Chart

Rossari Biotech Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Equity
Get a 7-Day Free Trial Premium Member Only 8,051.64 9,151.66 10,477.28 11,854.49 13,333.49

Rossari Biotech Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 12,514.99 0.00 13,333.49 0.00
BOM:543213
84GF Score
Rossari Biotech Ltd BOM:543213
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rossari Biotech Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Rossari Biotech's Total Equity for the fiscal year that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=22887.92-9554.43
=13,333

Rossari Biotech's Total Equity for the quarter that ended in Jun. 2026 is calculated as

Total Equity=Total Assets(Q: Jun. 2026 )-Total Liabilities(Q: Jun. 2026 )
=N/A-N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ₹0 Mil mean?
Rossari Biotech (BOM:543213) has a Total Equity of ₹0 Mil as of Jun. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Rossari Biotech and its competitors.
Is Rossari Biotech's Total Equity too high?
Rossari Biotech's current Total Equity is ₹0 Mil. Overall, Rossari Biotech has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Rossari Biotech's Total Equity compare to LIN and SHW?
Rossari Biotech's Total Equity of ₹0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Chemicals company?
A good Total Equity depends on the Chemicals industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Rossari Biotech and its competitors. Rossari Biotech's current Total Equity is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rossari Biotech stock overvalued right now?
Based on GuruFocus' analysis, Rossari Biotech (BOM:543213) is currently considered Possible Value Trap. The stock's GF Value™ is ₹967.22, compared to a current price of ₹489.30 — trading 49.4% below its estimated fair value. The current Total Equity is ₹0 Mil. Rossari Biotech's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Rossari Biotech (BOM:543213), the current Total Equity is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rossari Biotech (BOM:543213) Overvalued in 2026?

Based on GuruFocus' analysis, Rossari Biotech stock appears to be undervalued. The current stock price of ₹489.30 is trading 49.4% below its estimated GF Value™ of ₹967.22. GuruFocus considers Rossari Biotech to be Possible Value Trap.

Key valuation signals for BOM:543213:

  • Total Equity: ₹0 Mil
  • GF Value™: ₹967.22 vs. price of ₹489.30 (49.4% below fair value)
  • GF Score™: 84/100 with 4 warning signs

No single metric tells the full story. See the BOM:543213 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rossari Biotech Business Description

Other Exchanges ROSSARI:India
Address Rossari House, Lal Bahadur Shastri Marg, Golden Oak, Opp. Mahindra Showroom, Vikhroli (West), Surya Nagar, Mumbai, MH, IND, 400079
Rossari Biotech Ltd is a specialty chemical manufacturing company. It provides customized solutions to specific industrial and production requirements of its customers in the FMCG, apparel, poultry, and animal feed industries through its product portfolio comprising home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its business is organized into three categories: home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its products include soaps and detergents, paints, inks and coatings, ceramics and tiles, water treatment chemicals, pulp and paper, and cleaning chemical formulations, among others. The company generates the majority revenue from India.
84GF Score

Get the complete analysis for BOM:543213

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹489.30
Price
₹967.22
GF Value